Page last updated: 2024-10-23

baclofen and Lupus Erythematosus, Systemic

baclofen has been researched along with Lupus Erythematosus, Systemic in 1 studies

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor-Gjevre, RM1
Gjevre, JA1

Other Studies

1 other study available for baclofen and Lupus Erythematosus, Systemic

ArticleYear
Anti-glutamic acid decarboxylase antibodies in a patient with systemic lupus erythematosus and fibromyalgia symptoms.
    Lupus, 2005, Volume: 14, Issue:6

    Topics: Adult; Autoantibodies; Baclofen; Female; Fibromyalgia; GABA Agonists; Glutamate Decarboxylase; Human

2005